uncontrolled study, eradication of H pylon (measured by urea breath test) was achieved in 87% of their patients. Disturbance of taste was the most common side effect.
The different prevalence of H pylon in our patients with a bleeding duodenal ulcer (73%) as opposed to those with a non-bleeding duodenal ulcer (92%) has not been reported to date. Previous studies have recorded a consistently high H pyloni colonisation rate in patients with duodenal ulcer-usually over 90%-but such patients have either a non-bleeding duodenal ulcer or patient details are not stated. We observed that patients with recurrent duodenal ulcers may be divided loosely into those whose ulcer repeatedly bleeds and those whose ulcer repeatedly causes pain. It is impossible to say from our data whether the differing prevalences ofH pylon observed between bleeding and non-bleeding duodenal In conclusion, we believe that regimens ofmore than one week to eradicate H pylori are no longer necessary. One week of bismuth, metronidazole, and tetracycline seems to be effective and safe and to have minimal side effects.
We thank Miss P Y L Yiu for excellent technical support. This study was supported by a grant from the Croucher Foundation. 
Patients, methods, and results
The study was carried out in 20 lupus anticoagulant negative women aged 26-43 (mean 33) years with two or more (range 2-4, mean 2 6) fetal losses occurring in the first (76%) or second (24%) trimester. We also studied 18 lupus anticoagulant positive women aged 23-41 (mean 31) years with two or more (range 2-6, mean 3) fetal losses occurring in the first (71%) or second (29%) trimester.
Patients were screened for systemic diseases, diabetes mellitus, chromosome abnormalities in a parent, uterine abnormalities, and endometrial or hormonal luteal phase defects. Thirteen of the lupus anticoagulant positive patients had systemic lupus erythematosus, diagnosed according to American Tissue plasminogen activator antigen concentrations before and after stasis, plasminogen activator inhibitor antigen concentrations, and plasminogen activator inhibitor activities in lupus anticoagulant negative and lupus anticoagulant positive patients with repeated fetal loss, in healthy subjects, and in lupus anticoagulant negative women with systemic lupus erythematosus (SLE) and no fetal loss. Figures are means (SD) The table shows that tissue plasminogen activator concentration assessed before and after stasis was similar in lupus anticoagulant negative and lupus anticoagulant positive women with recurrent abortions and in healthy subjects. By contrast, values of plasminogen activator inhibitor antigen and activity were significantly higher in lupus anticoagulant positive women than in lupus anticoagulant negative women and healthy subjects. Finally, lupus anticoagulant negative women with systemic lupus erythematosus showed fibrinolytic parameters similar to those of healthy subjects and lupus anticoagulant negative patients free of systemic lupus erythematosus.
Comment
Impaired fibrinolytic capacity in lupus anticoagulant negative women has been described as a possible pathophysiological mechanism of placental infarction in early recurrent spontaneous abortions, but our findings are not confirmatory. Normal tissue plasminogen activator antigen release and basal normal values of plasminogen activator inhibitor antigen and activity did not suggest an imbalance of the fibrinolytic system in lupus anticoagulant negative women with repeated fetal loss. Conversely, the association between fibrinolytic impairment and lupus anticoagulant (previously described in patients with systemic lupus erythematosus and a history of thrombosis4) was confirmed and extended in lupus anticoagulant positive patients with repeated fetal loss. This fibrinolytic imbalance was primarily due to raised values of plasminogen activator inhibitor in the circulation while the release of tissue plasminogen activator antigen, which measures free tissue plasminogen activator and tissue plasminogen activator and plasminogen activator inhibitor complexes, was unaffected.
In conclusion, our findings suggest that an imbalance of the fibrinolytic system does not seem to be a typical feature of lupus anticoagulant negative women with a history of repeated fetal loss. By contrast, the occurrence of repeated abortions often found associated with placental infarctions in lupus anticoagulant positive women5 may be linked to high circulating concentrations of plasminogen activator inhibitor.
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